KalVista Pharmaceuticals (NASDAQ:KALV) Issues Earnings Results
KalVista Pharmaceuticals (NASDAQ:KALV – Get Free Report) issued its quarterly earnings results on Thursday. The specialty pharmaceutical company reported ($0.80) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.76) by ($0.04), MarketWatch Earnings reports. KalVista Pharmaceuticals Stock Performance Shares of NASDAQ KALV opened at $8.16 on Friday. The company has a 50 […]